Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • The endocannabinoid system in normal and pathological brain ageing (2011)

    Aging is associated with a decline in motor coordination, sensory abilities, attention and cognitive performance, which together are responsible for the deficits in learning and memory tasks. This research was based on studying the cellular and molecular mechanisms that underlie the protective effect of the cannabinoid system on brain aging. View study

  • The Endocannabinoid System Is Dysregulated in Multiple Sclerosis and in Experimental Autoimmune Encephalomyelitis (2016)

    The ability of cannabinoids to modulate both neuronal inflammatory and degenerative damage led to investigations into the potential benefits of such compounds in multiple sclerosis (MS) and in animal models of this disorder. The present study focused on measuring endocannabinoid levels, metabolism and binding, and physiological activities in 26 patients with MS View study

  • The endocannabinoid system- a new target for the regulation of energy balance and metabolism (2007)

    Now there is solid evidence to support the notion that the endocannabinoid system (EC) has very significant effects.on the energetic balance and the metabolism through the central control of the appetite and by affecting the peripheral metabolism.This research focused on the study of the endocannabinoid system as a new regulator of energy balance and metabolism. View study

  • The Endocannabinoid System, Cannabinoids, and Pain (2013)

    View study

  • The Endocannabinoid-CB Receptor System: Importance for development and in pediatric disease (2004)

    Endogenous cannabinoids (endocannabinoids) and their CB1 and CB2 cannabinoid receptors are present from the early stages of gestation and perform a series of vital functions for the developing organism.The present research was based on studying the endocannabinoid receptor system (CB) as well as defining its importance in the treatment of pediatric diseases. View study

  • The endogenous cannabinoid system and its role in nociceptive behavior (2004)

    In this research, a review was made of recent genetic, behavioral and pharmacological studies that have proven the function of the endocannabinoid system in the sensation of pain. View study

  • The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy (2003)

    These studies demonstrate the role of the endogenous cannabinoid system in the regulation of seizure activity and the modulation of neuroexitation, which demonstrates the potential of cannabinoids as anticonvulsants. View study

  • The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells (2010)

    This research was based on the study of the potential efficacy of endogenous cannabinoid anandamide to induce cell death in colon cancer cells resistant to apoptosis. View study

  • The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas (2010)

    It is desired to analyze in this research whether the level of expression of CB1 and CB2 receptors determines its efficacy in the induction of apoptosis in astrocytomas View study

  • The influence of cannabinoids on generic traits of neurodegeneration (2013)

    Modulation of the cannabinoid system has shown beneficial effects and constitutes a possibility for the treatment of neurodegenerative disorders such as Parkinson’s disease. View study

  • The intersection between cannabis and cancer in the United States (2012)

    In the last 15 years, there has been a major change in the laws governing the medical use of cannabis in the United States. The present review focused on examining the current and potential roles of cannabis and cannabinoids in cancer care View study

  • The Nonpsychoactive Cannabinoid Cannabidiol Inhibits 5-Hydroxytryptamine3A Receptor-Mediated Currents in Xenopus laevis Oocytes (2010)

    This research focused on investigating the effect of the non-psychotropic cannabinoid derived from the plant, cannabidiol (CBD), on the function of 3A hydroxytryptamine (5-HT) receptors expressed in Xenopus laevis oocytes using pinching techniques. Two electrode voltage. View study